ETrade Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,173
Closed -$562K 932
2020
Q1
$562K Sell
3,173
-1,830
-37% -$345K 0.01% 439
2019
Q4
$956K Sell
5,003
-5,261
-51% -$949K 0.02% 370
2019
Q3
$1.73M Sell
10,264
-26,162
-72% -$4.26M 0.04% 229
2019
Q2
$6.1M Buy
36,426
+4,006
+12% +$555K 0.16% 66
2019
Q1
$4.75M Buy
32,420
+10,248
+46% +$1.49M 0.14% 78
2018
Q4
$2.96M Sell
22,172
-3,318
-13% -$544K 0.1% 116
2018
Q3
$4.86M Buy
25,490
+413
+2% +$75.9K 0.14% 82
2018
Q2
$4.18M Buy
25,077
+1,075
+4% +$173K 0.13% 83
2018
Q1
$4.04M Buy
24,002
+7,670
+47% +$1.29M 0.13% 85
2017
Q4
$2.67M Buy
16,332
+10,691
+190% +$1.92M 0.09% 133
2017
Q3
$1.16M Buy
5,641
+327
+6% +$76K 0.04% 297
2017
Q2
$1.29M Sell
5,314
-1,040
-16% -$244K 0.05% 210
2017
Q1
$1.52M Buy
6,354
+1,242
+24% +$289K 0.06% 183
2016
Q4
$1.07M Sell
5,112
-1,800
-26% -$373K 0.05% 218
2016
Q3
$1.59M Buy
6,912
+1,073
+18% +$262K 0.08% 156
2016
Q2
$1.35M Buy
5,839
+1,831
+46% +$422K 0.07% 161
2016
Q1
$1.07M Buy
4,008
+1,003
+33% +$287K 0.06% 186
2015
Q4
$939K Buy
3,005
+134
+5% +$39.9K 0.06% 196
2015
Q3
$780K Buy
2,871
+889
+45% +$273K 0.05% 216
2015
Q2
$601K Buy
1,982
+387
+24% +$115K 0.04% 262
2015
Q1
$474K Buy
1,595
+191
+14% +$54.5K 0.03% 294
2014
Q4
$362K Sell
1,404
-47
-3% -$11.7K 0.02% 367
2014
Q3
$350K Sell
1,451
-32
-2% -$7.16K 0.02% 332
2014
Q2
$330K Buy
1,483
+37
+3% +$7.66K 0.02% 291
2014
Q1
$297K Buy
1,446
+1,390
+2,482% +$275K 0.02% 272
2013
Q4
$9K Buy
56
+43
+331% +$6.72K ﹤0.01% 725
2013
Q3
$2K Hold
13
﹤0.01% 862
2013
Q2
$2K Buy
+13
New +$1.47K ﹤0.01% 808

Other funds holding AGN

ETrade Capital Management's AGN Position: Q2 2020 in Review

ETrade Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,173 shares — an estimated $562K sold.

ETrade Capital Management first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $6.1M in Q2 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • ETrade Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • ETrade Capital Management sold 3,173 Allergan plc shares in Q2 2020, an estimated $562K.
  • ETrade Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • ETrade Capital Management's Allergan plc position peaked at $6.1M in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on ETrade Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.